Clinical Trial Update: Validate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxytocin for peripheral analgesic effects in knee osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Osteoarthritis, Knee | Phase 2 | Status: WITHDRAWN